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Occurrence of Antimicrobial-Resistant Escherichia coli and Salmonella
enterica in the Beef Cattle Production and Processing Continuum
John W. Schmidt, Getahun E. Agga, Joseph M. Bosilevac, Dayna M. Brichta-Harhay, Steven D. Shackelford, Rong Wang,
Tommy L. Wheeler, Terrance M. Arthur
U.S. Department of Agriculture, Agricultural Research Service, Roman L. Hruska U.S. Meat Animal Research Center, Clay Center, Nebraska, USA
Specific concerns have been raised that third-generation cephalosporin-resistant (3GCr) Escherichia coli, trimethoprim-sulfa-
methoxazole-resistant (COTr) E. coli, 3GCr Salmonella enterica, and nalidixic acid-resistant (NALr) S. enterica may be present
in cattle production environments, persist through beef processing, and contaminate final products. The prevalences and con-
centrations of these organisms were determined in feces and hides (at feedlot and processing plant), pre-evisceration carcasses,
and final carcasses from three lots of fed cattle (n 184). The prevalences and concentrations were further determined for strip
loins from 103 of the carcasses. 3GCr Salmonellawas detected on 7.6% of hides during processing and was not detected on the
final carcasses or strip loins. NALr S. enterica was detected on only one hide. 3GCr E. coli and COTr E. coli were detected on
100.0% of hides during processing. Concentrations of 3GCr E. coli and COTr E. coli on hides were correlated with pre-eviscera-
tion carcass contamination. 3GCr E. coli and COTr E. coli were each detected on only 0.5% of final carcasses and were not de-
tected on strip loins. Five hundred and 42 isolates were screened for extraintestinal pathogenic E. coli (ExPEC) virulence-associ-
ated markers. Only two COTr E. coli isolates from hides were ExPEC, indicating that fed cattle products are not a significant
source of ExPEC causing human urinary tract infections. The very low prevalences of these organisms on final carcasses and
their absence on strip loins demonstrate that current sanitary dressing procedures and processing interventions are effective
against antimicrobial-resistant bacteria.
The prevalence of bacterial infections resistant to antimicrobialtherapy has been recognized as a critically important global
public health concern (1–6). A 2013 U.S. Centers for Disease Con-
trol (CDC) report identified 18 antimicrobial-resistant (AMR)
organisms as priority threats to human health, but it implicated
antimicrobial use in animal production as a factor contributing to
the incidence of only two of these AMR organisms (5). Regardless,
the contribution of meat animal production, including beef pro-
duction, to the occurrence of antimicrobial resistant human bac-
terial infections remains a prominent and contentious issue (7–
12). Prioritization of AMR organisms is difficult since bacterial
AMR is an ancient, natural, complex, and dynamic process (13,
14). Nonetheless, specific concerns have been raised about four
AMR bacteria present in beef cattle production, processing, and
finished products: nalidixic acid-resistant (NALr) nontyphoidal
Salmonella enterica (nontyphoidal S. enterica will be referred to
here as Salmonella), third-generation cephalosporin-resistant
(3GCr) Salmonella, 3GCr Escherichia coli, and trimethoprim-sul-
famethoxazole-resistant (COTr) E. coli (5, 15–18).
Human urinary tract infections (UTIs) caused by extraintesti-
nal pathogenic E. coli (ExPEC) have recently been described to
have possible food-borne origins that include beef products (19–
21). The folate synthesis inhibitor combination trimethoprim-
sulfamethoxazole (co-trimoxazole) is the preferred therapy for
UTI (22, 23), but clinicians have reported an increase in COTr E.
coli (24). COTr E. coli, ExPEC, and COTr ExPEC have been iso-
lated from retail beef products (21, 25), but to our knowledge
there are no published studies on COTr E. coli, ExPEC, and COTr
ExPEC in beef production and processing environments.
The dynamics of 3GCr E. coli, COTr E. coli, 3GCr Salmonella,
and NALr Salmonella subpopulations in beef cattle production
and processing environments have not been thoroughly investi-
gated. Elucidation of population dynamics in cattle production
and processing is important to understanding the food safety im-
pact of antimicrobial resistance in beef production, as prevalences
and concentrations of bacteria on cattle hides are strongly corre-
lated with carcass contamination during hide removal (26–29).
The U.S. National Antimicrobial Resistance Monitoring Sys-
tem (NARMS) programs’ surveillance of AMR food-borne patho-
gens in beef production is limited to culture of Salmonella from
ground beef (sampled both at processing and at retail) and from
beef carcass swabs and to culture of E. coli from a subset of retail
ground beef samples (25, 30, 31). NARMS surveillance does not
provide data required for determining the effectiveness of in-plant
processing interventions or risk analysis of food-borne bacteria
resistant to antimicrobials important to human medicine in pro-
duction environments (feedlots) or during processing (hides and
pre-evisceration carcasses prior to interventions). The objective of
the present study was to begin addressing these data gaps and to
determine the prevalence and concentrations of generic Salmo-
nella, 3GCr Salmonella, NALr Salmonella, generic E. coli, 3GCr E.
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coli, and COTr E. coli from feedlot, through processing, to final
products. We define “generic E. coli” and “generic Salmonella” as
all E. coli and all Salmonella, respectively, regardless of susceptibil-
ity to any antimicrobial agent or pathogenicity status. In addition,
generic E. coli, 3GCr E. coli, and COTr E. coli isolates were screened
for the presence of virulence-associated markers of human ExPEC
infections (21, 32).
MATERIALS AND METHODS
Cattle populations and samplingmethods. Three groups of fed beef cat-
tle, designated lot 1, lot 2, and lot 3, were examined in the present study.
Lot 1 and lot 2 were housed in the same Nebraska feedlot. Lot 3 cattle were
housed at a different Nebraska feedlot. All three lots of cattle were har-
vested at the same beef processing plant. Seven types of samples were
obtained: feedlot fecal, processing fecal, feedlot hide, processing hide, pre-
evisceration carcass, final carcass, and strip loin. No attempts were made
to match samples to individual animals.
Lots 1, 2, and 3 consisted of 74, 74, and 136 cattle, respectively. For lots
1 and 2, fecal and hide samples were obtained from all 74 head at the
feedlot in May 2013 and June 2013, respectively. For lot 3, fecal and hide
samples were obtained from 36 arbitrarily selected cattle at the feedlot in
October of 2013. Cattle were transported to the processing plant and
harvested 20 to 25 days after the feedlot samples were obtained. For lots 1
and 2, fecal, hide, pre-evisceration carcass (after hide removal but before
any carcass sanitizing treatments), and chilled final carcass samples were
obtained from all 74 carcasses. For lot 3, fecal, hide, pre-evisceration car-
cass, and chilled final carcass samples were obtained from 36 arbitrarily
selected carcasses. For lots 1 and 2, strip loins were obtained from 51 and
52 arbitrarily selected carcasses, respectively, vacuum-sealed, and stored
at 4°C. Purge was recovered these strip loins 1 week after storage. Strip loin
samples could not be collected for lot 3.
Fecal samples were collected by inserting a foam-tipped swab (catalog
no. 10812-022; VWR International, Buffalo Grove, IL) 3 to 5 cm into the
anus of each animal. Immediately after fecal sample collection, the swab
was placed into 5 ml of phosphate-buffered tryptic soy broth (TSB-PO; 30
g of TSB, 2.31 g of KH2PO4, and 12.54 g of K2HPO4 per liter, final pH 7.2;
Becton Dickinson, Franklin Lakes, NJ) (33). Hide samples were collected
from each animal by swabbing a 1,000-cm2 area located behind the shoul-
der with a sterile sponge (Whirl Pack; Nasco, Fort Atkinson, WI) prewet-
ted with 20-ml of buffered peptone water (BPW; Becton Dickinson). Im-
mediately after hide sampling, the sponge was placed into a sterile bag.
Feedlot fecal and hide samples were obtained while cattle were restrained
in a squeeze chute at the feedlot. Processing plant fecal and hide samples
were obtained at the processing plant immediately following exsanguina-
tion, prior to a hide wash cabinet.
Pre-evisceration and final carcass samples were obtained by swabbing
an 4,000-cm2 area from brisket to foreshank on a carcass half with a
sterile sponge (Whirl Pak) prewetted with 20 ml of BPW. Immediately
following carcass sampling, the sponge was placed into a sterile bag. Pre-
evisceration carcass samples were obtained after hide removal, prior to the
application of antimicrobial carcass decontamination steps. Final carcass
samples were obtained from carcasses chilled in the cooler overnight.
Strip loin samples were obtained by aseptically pipetting up to 26-ml
of purge, the liquid that forms within the package, from each individually
vacuum-sealed package containing a strip loin into a 50-ml conical test
tube.
Sample processing. For hide and carcass samples, sponges were ho-
mogenized by hand massage in the sample bags for 15 s, and a 1-ml
enumeration aliquot was removed (see Fig. S1 and S2 in the supplemental
material). First, 80 ml of TSB-PO was added to each sample, followed by
incubation at 25°C for 2 h and 42°C for 6 h and then held at 4°C until
secondary enrichments were performed the following day (33–35). Fecal
samples were suspended by vortexing for 30 s, and then a 1-ml enumera-
tion aliquot was removed (see Fig. S3 in the supplemental material). The
remaining fecal sample was then incubated at 42°C for 8 h and then held
at 4°C until secondary enrichments were performed the following day.
Strip loin purge samples were vortexed for 30 s, and a 1-ml enumeration
aliquot was removed (see Fig. S4 in the supplemental material). The re-
maining purge was combined with TSB-PO in a 1:10 ratio (e.g., 25 ml of
purge was combined with 225 ml of TSB-PO) and incubated at 25°C for 2
h and 42°C for 6 h and then held at 4°C until secondary enrichments were
performed the following day.
GenericE. coli, 3GCrE. coli, andCOTrE. coli enumeration. For fecal,
hide, and pre-evisceration carcass samples, generic E. coli, 3GCr E. coli,
and COTr E. coli were each enumerated by spiral plating using a Spiral
plater (Spiral Biotech, Norwood, MA), with 50-l aliquots of appropriate
dilutions of the enumeration aliquoted onto CHROMagar E. coli (CEC)
plates (DRG International, Inc., Springfield, NJ), CEC plates supple-
mented with 2 mg liter1 of cefotaxime (CECCTX), and CEC plates
supplemented with 4 mg liter1 of trimethoprim and 76 mg liter1 sul-
famethoxazole (CECCOT), respectively (see Fig. S1 and S3 in the sup-
plemental material). All antimicrobials were obtained from Sigma-Al-
drich Corp., St. Louis, MO, unless otherwise stated. Supplementation of
media with cefotaxime to enumerate 3GCr E. coli has been described pre-
viously (36, 37). The concentrations of trimethoprim and sulfamethoxa-
zole added to CEC were set to match the resistance breakpoint for COTr E.
coli described in the most recently available NARMS Retail Meat Report
(25). Plates were incubated overnight at 37°C. Blue colonies on CEC,
CECCTX, and CECCOT were enumerated as presumptive generic E.
coli, 3GCr E. coli, and COTr E. coli, respectively. From each plate up to two
presumptive colonies were inoculated into TSB and incubated overnight
at 37°C. Then, an aliquot of overnight culture was removed, combined
with BAX lysis buffer (DuPont Qualicon, Inc., Wilmington, DE) and in-
cubated according to the manufacturer’s instructions to generate tem-
plate DNA for molecular assays. An aliquot of each DNA lysate was used
to confirm the presumptive colonies as E. coli by multiplex PCR for the
presence of lacY, lacZ, cyd, and uidA genes (38). Glycerol was added to
each overnight TSB culture to a final concentration of 15% and preserved
at20°C. Colony DNA lysates were preserved at20°C.
Generic Salmonella, 3GCr Salmonella, and NALr Salmonella enu-
meration. For fecal, hide, and pre-evisceration carcass samples generic
Salmonella, 3GCr Salmonella, and NALr Salmonellawere each enumerated
by spiral plating, using a Spiral plater (Spiral Biotech), 50-l aliquots of
the enumeration aliquot onto xylose-lysine-desoxycholate agar (Remel,
Inc., Lenexa, KS) plates supplemented with 4.6 mg liter1 tergitol (also
known as niaproof), 15 mg liter1 novobiocin, and 5 mg liter1 cefesulo-
din (XLDtnc) (35), xylose-lysine-desoxycholate agar plates supplemented
with 2 mg liter1 cefotaxime (XLDCTX), and xylose-lysine-desoxy-
cholate agar plates supplemented with 32 mg liter1 nalidixic acid
(XLDNAL), respectively (see Fig. S1 and S3 in the supplemental mate-
rial). Salmonella enumeration by direct plating onto XLDtnc was described
previously (35). The concentration of cefotaxime used in XLDCTX
plates was based on the recommendations by the European Food Safety
Authority (39). The concentration of nalidixic acid used to supplement
XLD media was based on the resistance breakpoint for NALr Salmonella
described in the most recently available NARMS retail meat report (25).
Plates were incubated overnight at 37°C and then held at 25°C for up to 72
h to allow H2S production and black color development. Black colonies
on XLDtnc, XLDCTX, and XLDNAL plates were counted as presump-
tive generic Salmonella, 3GCr Salmonella, and NALr Salmonella, respec-
tively. For confirmation, from each plate up to two presumptive colonies
were inoculated into TSB and incubated overnight at 37°C. From each
overnight TSB culture, an aliquot was removed and combined with BAX
lysis buffer, followed by incubation according to the manufacturer’s in-
structions to generate template DNA for molecular assays. An aliquot of
each DNA lysate was used to confirm the presumptive colonies as Salmo-
nella by PCR for the invA gene (40, 41). Glycerol was added to each
overnight TSB culture to a final concentration of 15% and preserved at
20°C. Colony DNA lysates were preserved at20°C.
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Generic E. coli, 3GCr E. coli, and COTr E. coli prevalences. For all
samples secondary enrichments were prepared by combining 0.5-ml ali-
quots of enrichment with 2.5 ml of MacConkey (MAC) broth (Becton
Dickinson), 2.5 ml of MAC broth supplemented with 2.4 mg liter1 ce-
fotaxime (MACCTX), and 2.5-ml of MAC broth supplemented with 4.8
mg liter1 trimethoprim and 91.2 mg liter1 sulfamethoxazole
(MACCOT). Secondary enrichments were and incubated overnight at
42°C. MAC, MACCTX, and MACCOT secondary enrichments were
then struck onto CEC, CECCTX, and CECCOT plates, respectively,
followed by incubation overnight at 37°C (see Fig. S1, S2, S3, and S4 in
the supplemental material). Blue colonies on CEC, CECCTX, and
CECCOT plates were considered presumptive generic E. coli, 3GCr E.
coli, and COTr E. coli, respectively. From each plate up to two presumptive
colonies were inoculated into TSB and incubated overnight at 37°C. Pre-
sumptive E. coli was PCR confirmed as E. coli and preserved as described
above.
Generic Salmonella, 3GCr Salmonella, and NALr Salmonella preva-
lences. For all samples, 1 ml of enrichment was combined with 20 l of
Salmonella-specific immunomagnetic separation beads (Life Technolo-
gies, Grand Island, NY) (42). The bacterium-bead complex was extracted,
placed into Rappaport-Vassiliadis soy peptone broth (RVS; Remel), and
incubated at 42°C overnight (see Fig. S1, S2, S3, and S4 in the supplemen-
tal material). The RVS selective enrichment was then swabbed onto
XLDtnc, XLDCTX, and XLDNAL plates. Plates were incubated over-
night at 37°C and then held at 25°C for up to 72 h to allow H2S production
and black color development. From each plate, up to two presumptive
Salmonella colonies were selected for confirmation by PCR for the pres-
ence of the Salmonella-specific portion of the invA gene as described
above.
Enumeration of final carcass and strip loin samples. For final carcass
and strip loin samples, the 1-ml enumeration aliquots were applied to
PetriFilm EB plates (3M Microbiology, St. Paul, MN) and were incubated
according to the manufacturer’s instructions (see Fig. S2 and S4 in the
supplemental material). Plates were then held at 4°C to await prevalence
results. PetriFilm EB plates corresponding to samples found to be preva-
lent for generic E. coli, 3GCr E. coli, COTr E. coli, generic Salmonella, 3GCr
Salmonella, or NALr Salmonellawas replica plated onto CEC, CECCTX,
CECCOT, XLDtnc, XLDCTX, or XLDNAL plates, respectively.
Plates were incubated and enumerated, selected colonies were grown
overnight, lysates were prepared, lysates were PCR confirmed, and over-
night growth was preserved as described above.
Calculation of sample concentrations. Fecal sample enumeration
plate counts were converted to log CFU/swab values. The lower limit of
enumeration from fecal samples was 2.00 log CFU/swab, and the theoret-
ical lower limit of prevalence detection was 0.00 log CFU/swab. Fecal
samples with no confirmed colonies on enumeration plates, but with con-
firmed colonies on prevalence plates were assumed to have a concentra-
tion between 0.00 and 1.99 log CFU/swab.
Hide sample enumeration plate counts were converted to log CFU/
100-cm2 values. The lower limit of enumeration from hide samples was
1.60 log CFU/100 cm2, and the theoretical lower limit of prevalence de-
tection was 1.00 log CFU/100 cm2. Hide samples with no confirmed
colonies on enumeration plates but with confirmed colonies on preva-
lence plates were assumed to have a concentration between 1.00 and
1.60 log CFU/100 cm2.
Pre-evisceration enumeration plate counts were converted to log
CFU/100-cm2 values. The lower limit of enumeration from pre-eviscera-
tion carcass samples was 1.00 log CFU/100 cm2, and the theoretical lower
limit of prevalence detection was 1.60 log CFU/100 cm2. Pre-eviscera-
tion carcass samples with no confirmed colonies on enumeration plates
but with confirmed colonies on prevalence plates were assumed to have a
concentration between1.60 and 0.99 log CFU/100 cm2.
Final carcass enumeration plate counts were converted to log CFU/
100-cm2 values. The lower limit of enumeration from final carcass sam-
ples was0.30 log CFU/100 cm2, and the theoretical lower limit of prev-
alence detection was1.60 log CFU/100 cm2. Final carcass samples with
no confirmed colonies on enumeration plates, but with confirmed colo-
nies on prevalence plates were assumed to have a concentration between
1.60 and0.31 log CFU/100 cm2.
Strip loin purge enumeration plate counts were converted to log
CFU/ml values. The lower limit of enumeration from strip loin purge was
0.00 log CFU/ml, and the theoretical lower limit of prevalence detection
was1.40 log CFU/ml. Strip loin purge samples with no confirmed col-
onies on enumeration plates but with confirmed colonies on prevalence
plates were assumed to have a concentration between 1.40 and 0.01
log CFU/ml.
Genotyping and antimicrobial susceptibility testing of generic E.
coli, 3GCr E. coli, and COTr E. coli isolates. Samples were grouped by lot
(1, 2, or 3) and sample type (feedlot fecal, processing fecal, feedlot hide,
processing hide, pre-evisceration carcass, final carcass, and purge from
strip loin). For each group the 12 samples with the highest concentrations
of generic E. coli, 3GCr E. coli, and COTr E. coli were selected. When there
were fewer than 12 samples in a group with enumerable concentrations,
the remaining selections were arbitrarily made from samples that were
prevalence positive but not enumerable. For each generic E. coli, 3GCr E.
coli, or COTr E. coli sample selected a confirmed colony was struck onto a
CEC, CECCTX, or CECCOT plate, respectively. Plates were incu-
bated at 37°C overnight, and then a single isolated blue colony was se-
lected and streaked onto a Trypticase soy agar (TSA) plate (Becton Dick-
inson), followed by incubation at 37°C overnight. One isolated colony
from each TSA plate was inoculated into a 0.7-ml TSB culture and incu-
bated overnight at 37°C. An aliquot of overnight culture was then re-
moved, combined with BAX lysis buffer, and incubated according to the
manufacturer’s instructions to generate template DNA for molecular as-
says. Glycerol was added to each overnight TSB culture to a final concen-
tration of 15% and preserved at 80°C. Isolate DNA lysates were pre-
served at20°C. Isolate DNA lysates were used to reconfirm the isolates
were E. coli by multiplex PCR for the presence of lacY, lacZ, cyd, and uidA
genes (38). Isolate DNA lysates were also tested with a multiplex PCR to
determine the presence of five markers associated with ExPEC virulence,
afa/dra, iutA, kpsMT II, papA, and papC (papA and papC were amplified
separately but analyzed together as a single marker), and sfa/foc, using the
primers and conditions described by Xia et al. (21). Isolates harboring two
or more virulence markers were classified as ExPEC (21, 43).
3GCr E. coli isolate DNA lysates were subjected to PCR using the prim-
ers and conditions described by Kozak et al. (44) and Cottell et al. (45) to
determine the presence of blaCMY genes and blaCTX-M genes, respectively.
COTr E. coli isolate DNA lysates were subjected to PCR using the primers
and conditions described by Kozak et al. (44) to determine the presence of
sul1, sul2, and sul3 genes. COTr E. coli isolate DNA lysates were subjected
to PCR using the primers and conditions described by Grape et al. (46) to
determine the presence of dfrA1, dfrA5, dfrA7/dfrA17, and dfrA12 genes.
Antimicrobial susceptibility testing was performed with 3GCr E. coli
and COTr E. coli isolates using the Sensititre broth microdilution system
and CMV2AGNF plates (TREK Diagnostic Systems, Cleveland, OH) to
determine the MICs for each of 15 antimicrobial agents. The following
organisms were used as quality control strains in the antimicrobial sensi-
tivity assays: Pseudomonas aeruginosa ATCC 27853, E. coli ATCC 25922,
and Staphylococcus aureus ATCC 25923. The antimicrobials and break-
points for resistance in this panel were as follows: amoxicillin and clavu-
lanic acid (AMC),32 and16g ml1, respectively; ampicillin (AMP),
32 g ml1; azithromycin (AZI),32 g ml1; cefoxitin (FOX),32
g ml1; ceftiofur (TIO),8 g ml1; ceftriaxone (AXO),4 g ml1;
chloramphenicol (CHL),32g ml1; ciprofloxacin (CIP),4g ml1;
gentamicin (GEN),16 g ml1; kanamycin (KAN),64 g ml1; na-
lidixic acid (NAL), 32 g ml1; streptomycin (STR), 64 g ml1;
sulfisoxazole (FIS),512g ml1; tetracycline (TET),16g ml1; and
trimethoprim and sulfamethoxazole (COT), 4 and 76 g ml1, re-
spectively. Antimicrobial breakpoints and three-letter abbreviations were
as described in the most recently available NARMS retail meat report (25).
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Genotyping and antimicrobial susceptibility testing of generic Sal-
monella isolates, 3GCr Salmonella, andNALr Salmonella isolates. Sam-
ples were grouped by lot (1, 2, or 3) and sample type (feedlot fecal, pro-
cessing fecal, feedlot hide, processing hide, and pre-evisceration carcass).
For each group, the 12 samples with the highest concentrations of generic
Salmonella, 3GCr Salmonella, and NALr Salmonella were selected. When
there were fewer than 12 samples in a group with enumerable concentra-
tions, the remaining selections were arbitrarily made from samples that
were prevalence positive but not enumerable. For each generic Salmo-
nella, 3GCr Salmonella, or NALr Salmonella sample selected a confirmed
colony was struck onto an XLDtnc, XLDCTX, or XLDNAL plate, re-
spectively. Plates were incubated at 37°C overnight, and then a single
isolated black colony was selected, streaked onto a TSA plate, and incu-
bated at 37°C overnight. One isolated colony from each TSA plate was
inoculated into a 0.7-ml TSB culture, followed by incubation overnight at
37°C. An aliquot of overnight culture was then removed, combined with
BAX lysis buffer, and incubated according to the manufacturer’s instruc-
tions to generate template DNA for molecular assays. Glycerol was added
to each overnight TSB culture to a final concentration of 15% and pre-
served at80°C. Isolate DNA lysates were used to reconfirm the isolates
were Salmonella by PCR for the presence of the invA gene (40, 41). 3GCr
Salmonella isolate DNA lysates were subjected to PCR using the primers
and conditions described by Kozak et al. (44) and Cottell et al. (45) to
determine the presence of blaCMY and blaCTX-M genes, respectively.
Antimicrobial susceptibility testing was performed using the Sensititre
broth microdilution system and CMV2AGNF plates as described above
except the resistance breakpoint for CIP was lowered to 1 g ml1 as
described for Salmonella in the most recently available NARMS retail
meat report (25).
ExPEC virulence-associated genotyping of generic, COTr, and 3GCr
E. coli colony confirmation lysates from carcass and strip loin samples.
Confirmed generic E. coli, 3GCr E. coli, and COTr E. coli colony DNA
lysates from pre-evisceration carcass, final carcass, and strip loin samples
were examined for the presence of five ExPEC markers associated with
virulence and interpreted as described above. Samples with at least one
ExPEC colony were considered ExPEC prevalent.
RESULTS
Fecal samples obtained at feedlots. Generic E. coli was present in
100% of the fecal samples obtained at feedlots (Table 1). Concen-
trations of generic E. coli ranged from 4.00 to 7.54 log CFU/swab;
however, 94.0% of the samples contained generic E. coli concen-
trations 5.00 log CFU/swab. 3GCr E. coli prevalence in fecal
samples obtained at feedlots was 82.6%. 3GCrE. coliwas present at
concentrations up to 3.62 log CFU/swab, but concentrations were
between 0.00 and 1.99 log CFU/swab in 62.0% of feedlot fecal
samples. The COTr E. coli fecal prevalence at feedlots was 98.4%.
COTr E. coli was detected at concentrations up to 5.39 log CFU/
swab, but the COTr E. coli concentrations were between 0.00 and
3.99 log CFU/swab in 94.0% of feces.
Generic Salmonella, 3GCr Salmonella, and NALr Salmonella
were detected in 5.4, 0.5, and 0.0% of fecal samples obtained at
feedlots, respectively (Table 1). Only feedlot fecal samples ob-
tained from lot 3 cattle contained Salmonella. Salmonella was
present at concentrations of up to 2.00 log CFU/swab (Table 1).
Hides sampled at feedlots. Prevalences of generic E. coli, 3GCr
E. coli, and COTr E. coli on hides at feedlots were 100.0, 89.1, and
100.0%, respectively (Table 2). Generic E. coli concentrations on
hides at feedlots ranged between 3.53 and 6.90 log CFU/100 cm2,
but 94.0% of the hides harbored generic E. coli at concentrations
between 4.00 and 5.99 log CFU/100 cm2. 3GCr E. coli was detected
TABLE 1 Prevalences and concentrations of E. coli and Salmonella in fecal samples obtained at feedlots
Organism and lota
No.
sampled
%
prevalence
Frequency of fecal samples with indicated concn (log CFU/swab)
0.00–1.99 2.00–2.99 3.00–3.99 4.00–4.99 5.00–5.99 6.00–6.99 7.00–7.99
Generic E. coli 184 100.0 0 0 0 11 50 120 3
Lot 1 74 100.0 0 0 0 0 10 64 0
Lot 2 74 100.0 0 0 0 0 19 52 3
Lot 3 36 100.0 0 0 0 11 21 4 0
3GCr E. coli 184 82.6 114 32 6 0 0 0 0
Lot 1 74 60.8 33 12 0 0 0 0 0
Lot 2 74 98.6 55 13 5 0 0 0 0
Lot 3 36 94.4 26 7 1 0 0 0 0
COTr E. coli 184 98.4 81 52 40 7 1 0 0
Lot 1 74 98.6 18 24 26 5 0 0 0
Lot 2 74 100.0 39 20 12 2 1 0 0
Lot 3 36 94.4 24 8 2 0 0 0 0
Generic Salmonella 184 5.4 7 3 0 0 0 0 0
Lot 1 74 0.0 0 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 27.8 7 3 0 0 0 0 0
3GCr Salmonella 184 0.5 1 0 0 0 0 0 0
Lot 1 74 0.0 0 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 2.8 1 0 0 0 0 0 0
NALr Salmonella 184 0.0 0 0 0 0 0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; NALr, nalidixic acid resistant.
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on hides sampled at feedlots at concentrations up to 2.78 log CFU/
100 cm2, but 88.0% of the hides had 3GCr E. coli concentrations
that were between1.00 and 1.59 log CFU/100 cm2. COTr E. coli
was detected on hides sampled at feedlots at concentrations up to
3.89 log CFU/100 cm2; however, 77.2% of hides had COTr E. coli
concentrations between1.00 and 1.59 log CFU/100 cm2.
Generic Salmonella, 3GCr Salmonella, and NALr Salmonella
were detected on 26.1, 10.9, and 0.0% of hides sampled at feedlots,
respectively (Table 2). No sample contained either generic or
3GCr Salmonella at concentrations 1.60 log CFU/100 cm2. Ge-
neric Salmonella prevalence on hides at feedlots varied by lot, with
prevalences of 8.1, 8.1, and 100.0% observed for lot 1, lot 2, and lot
3, respectively. 3GCr Salmonella was not detected on lot 1 or lot 2
hides but was detected on 55.6% of the lot 3 hides.
Fecal samples obtained at processing. Prevalences of generic
E. coli, 3GCr E. coli, and COTr E. coli in fecal samples at processing
were 100.0, 75.0, and 95.1%, respectively (Table 3). Generic E. coli
was present at concentrations between 4.00 and 7.87 log CFU/
swab, but in 86.4% of the samples the concentrations were5.00
log CFU/swab. 3GCr E. coli was present in fecal samples at pro-
cessing at concentrations up to 2.90 log CFU/swab, but in 63.0%
of the samples the concentrations were between 0.00 and 1.99 log
CFU/swab. Fecal samples obtained at processing contained COTr
E. coli at concentrations up to 4.76 log CFU/swab, but in 80.4% of
the samples the COTr E. coli concentrations were between 0.00
and 2.99 log CFU/swab.
Generic Salmonella, 3GCr Salmonella, and NALr Salmonella
prevalences were 44.6, 1.6, and 0.0% in fecal samples obtained at
processing, respectively (Table 3). The highest concentration of
Salmonella in a fecal sample obtained at processing was 2.78 log
CFU/swab. Generic Salmonella prevalences for lot 1, lot 2, and lot
3 were 20.3, 63.5, and 55.6%, respectively. All three processing
fecal samples with 3GCr Salmonella were from lot 3.
Hides sampled at processing. Generic E. coli, 3GCr E. coli, and
COTr E. coli were each present on 100% of hides sampled at pro-
cessing (Table 4). Generic E. coli concentrations on hides at pro-
cessing ranged between 4.00 and 7.04 log CFU/100 cm2, but the
distribution of the concentrations varied by lot. During process-
ing 94.6% of the lot 1 cattle hides had generic E. coli concentra-
tions between 6.00 and 7.04 log CFU/100 cm2, but 99.1% of the lot
2 and lot 3 hides had generic E. coli concentrations between 4.00
and 5.99 log CFU/100 cm2.
3GCrE. coli concentrations on cattle hides at processing ranged
from1.00 to 3.53 log CFU/100 cm2 (Table 4). Lot differences in
the distribution of 3GCr E. coli concentrations were observed. The
percentages of hides with 3GCr E. coli concentrations of1.60 log
CFU/100 cm2 were 81.1, 17.6, and 22.2% for lot 1, lot 2, and lot 3,
respectively.
COTr E. coli concentrations on hides at processing ranged be-
tween1.00 and 4.56 log CFU/100 cm2 (Table 4). Lot differences
in the distribution of the COTr E. coli concentrations were ob-
served. COTr E. coli hide concentrations of 4.00 log CFU/100
cm2 were 25.7, 6.8, and 0.0% for lot 1, lot 2, and lot 3, respectively.
Generic Salmonella was present on 99.5% of hides at process-
ing with concentrations up to 2.98 log CFU/100 cm2 (Table 4).
However, hides with concentrations of generic Salmonella1.60
log CFU/100 cm2 varied by lot: 10.8% for lot 1, 83.8% for lot 2, and
11.1% for lot 3. 3GCr Salmonella was present on 14 hides (one lot
1 hide and 13 lot 3 hides) and concentrations were never1.60 log
CFU/100 cm2. NALr Salmonella was detected on one hide.
TABLE 2 Prevalences and concentrations of E. coli and Salmonella on hides at feedlots
Organism and lota No. sampled % prevalence
Frequency of hides with indicated concn (log CFU/100 cm2)
–1.00 to 1.59 1.60–2.99 3.00–3.99 4.00–4.99 5.00–5.99 6.00–6.99 7.00–7.99
Generic E. coli 184 100.0 0 0 3 41 132 8 0
Lot 1 74 100.0 0 0 0 4 70 0 0
Lot 2 74 100.0 0 0 0 18 48 8 0
Lot 3 36 100.0 0 0 3 19 14 0 0
3GCr E. coli 184 89.1 162 2 0 0 0 0 0
Lot 1 74 81.1 60 0 0 0 0 0 0
Lot 2 74 91.9 66 2 0 0 0 0 0
Lot 3 36 100.0 36 0 0 0 0 0 0
COTr E. coli 184 100.0 142 35 7 0 0 0 0
Lot 1 74 100.0 42 25 7 0 0 0 0
Lot 2 74 100.0 64 10 0 0 0 0 0
Lot 3 36 100.0 36 0 0 0 0 0 0
Generic Salmonella 184 26.1 48 0 0 0 0 0 0
Lot 1 74 8.1 6 0 0 0 0 0 0
Lot 2 74 8.1 6 0 0 0 0 0 0
Lot 3 36 100.0 36 0 0 0 0 0 0
3GCr Salmonella 184 10.9 20 0 0 0 0 0 0
Lot 1 74 0.0 0 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 55.6 20 0 0 0 0 0 0
NALr Salmonella 184 0.0 0 0 0 0 0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; NALr, nalidixic acid resistant.
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Pre-evisceration carcasses. Prevalences of generic E. coli on
pre-evisceration carcasses were 100.0, 77.0, and 97.2% for lot 1, lot
2, and lot 3, respectively (Table 5). Percentages of pre-evisceration
carcasses with genericE. coli concentrations between 1.00 and 2.00
log CFU/100 cm2 were 36.5, 1.4, and 0.0% for lot 1, lot 2, and lot 3,
respectively.
3GCr E. coli and COTr E. coli were present on only 2.7 and
32.6% of pre-evisceration carcasses, respectively, and their con-
centrations on pre-evisceration carcasses were never 0.99 log
CFU/100 cm2 (Table 5). The prevalences of COTr E. coli on pre-
evisceration carcasses were 77.0, 2.7, and 2.8% for lot 1, lot 2, and
lot 3, respectively.
Generic Salmonella was present on four pre-evisceration car-
casses, all from lot 3 (Table 5). 3GCr Salmonella and NALr Salmo-
nella were not detected on any pre-evisceration carcass.
Final carcasses. Generic E. coli prevalences on final carcasses
were 91.9, 5.4, and 52.8% for lot 1, lot 2, and lot 3, respectively
(Table 6). Concentrations of generic E. coli on final carcasses
ranged from 1.60 to 1.10 log CFU/100 cm2, but generic E. coli
concentrations of– 0.30 log CFU/100 cm2 were present on lot
1 final carcasses. 3GCr E. coli was detected on only one final
carcass, from lot 1. COTr E. coli was also detected on one final
carcass, also from lot 1. Salmonella was not detected on final car-
casses (Table 6).
Strip loins. Generic E. coli prevalences were 86.5% in purge
samples obtained from 52 lot 1 strip loins and 86.2% in purge
samples obtained from 51 lot 2 strip loins. Concentrations of ge-
neric E. coli in purge from strip loins ranged from 1.40 to 1.30
log CFU/ml but were below the limit of enumeration (0.00 log
CFU/ml) in 98 (95.1%) samples. Concentrations in the five enu-
merable samples were 0.00, 0.00, 0.00, 0.30, and 1.30 log CFU/ml.
Strip loins from lot 3 were not available for microbial testing. 3GCr
E. coli, COTr E. coli, generic Salmonella, 3GCr Salmonella, and
NALr Salmonella were not detected in the purge obtained from
any strip loin sampled in the present study.
Antimicrobial susceptibilities, the presence of -lactamase
genes, and the presence of ExPEC virulence markers in 3GCr E.
coli isolates. All 150 3GCr E. coli isolates were resistant to AMP,
TIO, and AXO (Table 7). blaCMY was present in 96 (64.0%) iso-
lates, including one isolate in which blaCTX-M was also present. All
96 isolates with blaCMY were resistant to AUG and FOX. blaCTX-M
was present without the presence of blaCMY in 54 (36.0%) isolates;
none of these isolates were resistant to FOX, and only one was
resistant to AUG.
None of the 3GCr E. coli isolates were classified has ExPEC
since no isolate harbored more than one virulence marker (Table
8). Only one isolate possessed the iutA virulence marker; none of
the other virulence markers were detected from the other 149
3GCr E. coli isolates.
Antimicrobial susceptibilities, presence of dfrA genes, the
presence of sul genes, and the presence of ExPEC virulence
markers in COTr E. coli isolates. All 160 COTr E. coli isolates
examined were COTr and FISr (Table 7). The sul1, sul2, and sul3
genes were detected in 70.6, 39.4, and 22.5% of isolates, respec-
tively. All three sul genes were detected in 9.4% of isolates, two sul
genes were detected in 14.4% of isolates, one sul gene was detected
in 75.6% of isolates, and no sul gene was detected in 0.6% of
isolates. The dfrA1, dfrA5, dfrA7/dfrA17, and dfrA12 genes were
detected in 10.0, 51.3, 31.3, and 17.5% of isolates, respectively.
Three dfrA genes were detected in 4.4% of isolates, two dfrA genes
TABLE 3 Prevalences and concentrations of E. coli and Salmonella in fecal samples obtained at processing
Organism and lota
No.
sampled
%
prevalence
Frequency of fecal samples with indicated concn (log CFU/swab)
0.00–1.99 2.00–2.99 3.00–3.99 4.00–4.99 5.00–5.99 6.00–6.99 7.00–7.99
Generic E. coli 184 100.0 0 0 0 25 84 59 16
Lot 1 74 100.0 0 0 0 0 15 45 14
Lot 2 74 100.0 0 0 0 7 52 13 2
Lot 3 36 100.0 0 0 0 18 17 1 0
3GCr E. coli 184 75.0 116 22 0 0 0 0 0
Lot 1 74 64.9 41 7 0 0 0 0 0
Lot 2 74 81.1 53 7 0 0 0 0 0
Lot 3 36 83.3 22 8 0 0 0 0 0
COTr E. coli 184 95.1 81 67 24 3 0 0 0
Lot 1 74 98.6 29 26 15 3 0 0 0
Lot 2 74 98.6 27 37 9 0 0 0 0
Lot 3 36 80.6 25 4 0 0 0 0 0
Generic Salmonella 184 44.6 74 8 0 0 0 0 0
Lot 1 74 20.3 15 0 0 0 0 0 0
Lot 2 74 63.5 45 2 0 0 0 0 0
Lot 3 36 55.6 14 6 0 0 0 0 0
3GCr Salmonella 184 1.6 2 1 0 0 0 0 0
Lot 1 74 0.0 0 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 8.3 2 1 0 0 0 0 0
NALr Salmonella 184 0.0 0 0 0 0 0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; NALr, nalidixic acid resistant.
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were detected in 10.0% of isolates, one dfrA gene was detected in
76.9% of isolates, and none of the dfrA genes screened for were
detected in 8.8% of isolates.
Two (1.3%) of the 160 COTr E. coli isolates were identified as
ExPEC (Table 8). Both ExPEC isolates were obtained from hides
at processing, one each from lot 2 and lot 3. Each of the ExPEC
isolates contained the iutA and papC makers. The iutA virulence-
associated factor was detected from 50.6% of the COTr E. coli
isolates and was present in isolates obtained from each lot. The
papC gene was detected from only the two ExPEC isolates. The
afa/dra, sfa/foc, and papA virulence-associated factors were not
present in any of the COTr E. coli isolates.
Presence of ExPEC virulence markers in generic E. coli iso-
lates. None of the 232 generic E. coli isolates were ExPEC (Table
8). One ExPEC virulence-associated factor was present in 13.4%
of isolates. papA, iutA, papC, and kpsMT II were detected in 9.5,
1.7, 1.3, and 0.9% of generic E. coli isolates, respectively.
Prevalence of ExPEConpre-evisceration carcasses, final car-
casses, and strip loins. Colony lysates of generic E. coli, 3GCr E.
coli, and COTr E. coli from pre-evisceration carcass, final carcass,
and strip loin samples were also screened for the presence of Ex-
PEC virulence-associated factors. No colony lysate contained
more than one virulence factor. Thus, prevalences of 3GCr Ex-
PEC, COTr ExPEC, and generic ExPEC were 0.0% on pre-eviscer-
ation carcasses, final carcasses, and strip loins.
Antimicrobial susceptibilities of generic Salmonella isolates.
Of the 110 generic Salmonella isolates examined 79.1% were pan-
susceptible (Table 7). A total of 20.0% of the generic Salmonella
isolates were resistant to both FIS and TET, while one isolate
(0.9%) was TET resistant.
Antimicrobial susceptibilities and the presence of -lacta-
mase genes in 3GCr Salmonella isolates. All 37 3GCr Salmonella
isolates were resistant to AUG, AMP, TIO, and AXO (Table 7). All
37 isolates were susceptible to CIP, GEN, KAN, NAL, and COT.
All isolates but one (97.3%) were resistant to FOX. One isolate was
susceptible to FIS and TET. All 37 3GCr Salmonella isolates har-
bored blaCMY. blaCTX-M was not detected in any 3GC
r Salmonella
isolate.
Antimicrobial susceptibility of a NALr Salmonella isolate.
The sole NALr Salmonella isolate was resistant to AMP, CIP, GEN,
NAL, and TET but susceptible to AUG, AZI, FOX, TIO, AXO,
CHL, KAN, STR, FIS, and COT (Table 7).
DISCUSSION
The contamination of beef carcasses with bacterial populations on
the hides during hide removal is termed “hide-to-carcass trans-
fer.” The hide-to-carcass transfer of E. coli O157:H7 and Salmo-
nella has been demonstrated to be a prominent source of final
product contamination (27, 29, 47, 48). Since higher pathogen
concentrations on hides during processing are correlated with
higher rates of beef carcass contamination (29, 49, 50), we inves-
tigated here the concentrations and prevalences of AMR E. coli
and Salmonella in beef processing.
Although COTr E. coli was present on all 184 hides at process-
TABLE 4 Prevalences and concentrations of E. coli and Salmonella on hides at processing
Organism and lota
No.
sampled
%
prevalence
Frequency of hides with indicated concn (log CFU/100 cm2)
–1.00 to 1.59 1.60–2.99 3.00–3.99 4.00–4.99 5.00–5.99 6.00–6.99 7.00–7.99
Generic E. coli 184 100.0 0 0 0 45 68 69 2
Lot 1 74 100.0 0 0 0 0 4 68 2
Lot 2 74 100.0 0 0 0 16 57 1 0
Lot 3 36 100.0 0 0 0 29 7 0 0
3GCr E. coli 184 100.0 103 69 12 0 0 0 0
Lot 1 74 100.0 14 49 11 0 0 0 0
Lot 2 74 100.0 61 13 0 0 0 0 0
Lot 3 36 100.0 28 7 1 0 0 0 0
COTr E. coli 184 100.0 32 23 105 24 0 0 0
Lot 1 74 100.0 1 5 49 19 0 0 0
Lot 2 74 100.0 0 13 56 5 0 0 0
Lot 3 36 100.0 31 5 0 0 0 0 0
Generic Salmonella 184 99.5 109 74 0 0 0 0 0
Lot 1 74 100.0 66 8 0 0 0 0 0
Lot 2 74 100.0 12 62 0 0 0 0 0
Lot 3 36 97.2 31 4 0 0 0 0 0
3GCr Salmonella 184 7.6 14 0 0 0 0 0 0
Lot 1 74 1.4 1 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 36.1 12 1 0 0 0 0 0
NALr Salmonella 184 0.5 1 0 0 0 0 0 0
Lot 1 74 1.4 1 0 0 0 0 0 0
Lot 2 74 0.0 0 0 0 0 0 0 0
Lot 3 36 0.0 0 0 0 0 0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; NALr, nalidixic acid resistant.
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ing, lot 1 processing hides had a 25.7% incidence of concentra-
tions of COTr E. coli of4.00 log CFU/100 cm2, higher than the
6.8 and 0.0% incidences for lot 2 and lot 3, respectively (Table 4).
Fittingly, COTr E. coli pre-evisceration carcass prevalences were
77.0, 2.7, and 2.8% for lot 1, lot 2, and lot 3, respectively (Table 5).
The solitary final carcass contaminated with COTr E. coliwas from
lot 1 (Table 6).
3GCr E. coliwas present on all 184 hides sampled at processing,
but the 3GCr E. coli pre-evisceration carcass prevalences were 2.7,
0.0, and 8.3% for lot 1, lot 2, and lot 3, respectively (Tables 4 and
5). Accordingly, concentrations of 3GCr E. coli did not exceed 4.00
log CFU/100 cm2 on any hide at processing (Table 4). 3GCr Sal-
monella was not detected on any pre-evisceration carcass or final
carcass (Tables 5 and 6). Fittingly, 3GCr Salmonella was detected
on only 7.6% of hides during processing, and the hide concentra-
tions were1.60 log CFU/100 cm2 on only one hide (Table 4).
These results support the existing model of hide-to-carcass
transfer and demonstrate the importance of the concentrations of
AMR populations present on hides during processing. However, a
standardized threshold hide concentration to prevent hide-to-
carcass transfer should not be inferred from these results. Con-
taminant concentration on hides is not the sole factor influencing
hide-to-carcass transfer since other factors (proficiency in hy-
gienic hide removal, variation of in-plant interventions, etc.) also
impact to hide-to-carcass transfer significantly. For instance,
some processing plants with higher hide concentrations of E. coli
O157:H7 and Salmonella on incoming cattle have been demon-
strated to have lower rates of hide-to-carcass transfer than plants
with lower hide concentrations of E. coli O157:H7 and Salmonella
due to better hide removal technique (29, 49, 51).
Transportation from production environments to the process-
ing plant and the processing plant “lairage” environment (areas
cattle pass from arrival at the processing plant until shackling,
including holding pens, alleys, and chutes) have been demon-
strated to alter E. coli O157:H7 and Salmonella concentrations on
hides between feedlot and processing plant (50, 52). This process
has been termed “lairage contamination.” It was beyond the scope
of this study to irrefutably determine whether lairage contamina-
tion was responsible for alterations of AMR bacteria concentra-
tions on hides between feedlot and processing because of study
limitations, including the number of days between sampling at
feedlots and processing. In addition, sampling lairage environ-
ments, including trailers and subtyping isolates were beyond the
scope of the present study. Nevertheless, the results, especially for
lot 1, were consistent with lairage contamination. When lot 1 cat-
tle were sampled at the feedlot, no hide harbored 3GCr E. coli at
concentrations1.60 log CFU/100 cm2 (Table 2), but at process-
ing, 81.1% of the hides harbored 3GCr E. coli at concentrations
1.60 log CFU/100 cm2 (Table 4). In addition, lot 1 cattle with
fecal concentrations of 3GCr E. coli2.00 log CFU/swab dropped
from 16.2% at the feedlot to 9.5% at processing (Tables 1 and 3).
These observations were consistent with contamination of lot 1
hides with 3GCr E. coli in lairage. Greater alteration of COTr E. coli
hide concentrations were observed on lot 1 hides between feedlot
and processing. When sampled at the feedlot, only 9.4% of lot 1
hides had COTr E. coli concentrations 3.00 log CFU/100 cm2,
and no hide had COTr E. coli concentrations4.00 log CFU/100
cm2 (Table 2). At processing, 91.9% of lot 1 cattle hides had COTr
E. coli concentrations 3.00 log CFU/100 cm2, and concentra-
tions 4.00 log CFU/100 cm2 were detected on 25.7% of hides
(Table 4). These observations were consistent with contamination
of hides with COTr E. coli in lairage since the occurrence of lot 1
fecal samples with COTr E. coli concentrations 3.00 log CFU/
swab fell from 41.9 to 24.3% from feedlot to processing (Tables 1
and 3).
TABLE 5 Prevalences and concentrations of E. coli and Salmonella on
pre-evisceration carcasses
Organism and lota
No.
sampled
%
prevalence
Frequency of pre-
evisceration carcasses with
indicated concn (log CFU/
100 cm2)
–1.60 to 0.99 1.00–2.00
Generic E. coli 184 90.2 138 28
Lot 1 74 100.0 47 27
Lot 2 74 77.0 56 1
Lot 3 36 97.2 35 0
3GCr E. coli 184 2.7 5 0
Lot 1 74 2.7 2 0
Lot 2 74 0.0 0 0
Lot 3 36 8.3 3 0
COTr E. coli 184 32.6 60 0
Lot 1 74 77.0 57 0
Lot 2 74 2.7 2 0
Lot 3 36 2.8 1 0
Generic Salmonella 184 2.2 4 0
Lot 1 74 0.0 0 0
Lot 2 74 0.0 0 0
Lot 3 36 11.1 4 0
3GCr Salmonella 184 0.0 0 0
NALr Salmonella 184 0.0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-
sulfamethoxazole resistant; NALr, nalidixic acid resistant.
TABLE 6 Prevalences and concentrations of E. coli and Salmonella on
final carcasses
Organism and lota
No.
sampled
%
prevalence
Frequency of final carcasses with
indicated concn (log CFU/100 cm2)
–1.60 to
0.31 –0.30 to 0.99 1.00–1.99
Generic E. coli 184 49.5 26 60 5
Lot 1 74 91.9 3 60 5
Lot 2 74 5.4 4 0 0
Lot 3 36 52.8 19 0 0
3GCr E. coli 184 0.5 1 0 0
Lot 1 74 1.4 1 0 0
Lot 2 74 0.0 0 0 0
Lot 3 36 0.0 0 0 0
COTr E. coli 184 0.5 1 0 0
Lot 1 74 1.4 1 0 0
Lot 2 74 0.0 0 0 0
Lot 3 36 0.0 0 0 0
Generic Salmonella 184 0.0 0 0 0
3GCr Salmonella 184 0.0 0 0 0
NALr Salmonella 184 0.0 0 0 0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-
sulfamethoxazole resistant; NALr, nalidixic acid resistant.
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3GCr Salmonella is classified in the highest priority of antibi-
otic resistant food-borne pathogens, as 3rd-generation cephalo-
sporins (CTX, AXO) are the preferred therapies for serious juve-
nile human Salmonella infections (17, 53–57). Brichta-Harhay et
al. (58) demonstrated that 3GCr Salmonella spp. were a subpopu-
lation of generic Salmonella in beef processing environments us-
ing extensive antimicrobial susceptibility analysis of generic Sal-
monella isolates (i.e., isolates of colonies grown on media
permissive for Salmonella regardless of antimicrobial susceptibil-
ity), but the concentrations of 3GCr Salmonella subpopulations
could not be determined by Brichta-Harhay et al. since Salmonel-
la-specific media supplemented with third-generation cephalo-
sporins were not used to specifically enumerate 3GCr Salmonella.
In the present study, samples were plated onto XLDCTX
plates to enumerate 3GCr Salmonella, but enumerable levels were
present in only two samples. RVS secondary enrichment cultures
were plated on XLDCTX to improve detection when 3GCr Sal-
monella concentrations were below the lower limit of enumera-
tion. 3GCr Salmonella was detected in 38 samples, all of which
were hide or fecal samples. The absence of 3GCr Salmonella con-
tamination of pre-evisceration carcasses, final carcasses, and strip
loins was likely because the concentrations of 3GCr Salmonella
subpopulations on the hides at processing were at levels low
enough to make hide-to-carcass transfer unlikely. However, the
results demonstrated that the methods utilized here improved the
detection of 3GCr Salmonella on hides and in feces when concen-
trations were not enumerable. All 110 generic Salmonella isolates
subjected to broth microdilution susceptibility testing were sus-
ceptible to both third-generation cephalosporins (AXO and TIO)
tested, including 10 generic Salmonella isolates obtained from
samples (7 hide, 3 fecal) that were positive for 3GCr Salmonella.
Fluoroquinolones are the preferred therapy for adults with se-
rious Salmonella infections, and fluoroquinolone-resistant (FQr)
Salmonella is classified in the highest priority of antimicrobial-
resistant food-borne bacteria (17, 53–57). While FQr Salmonella
are rarely isolated from U.S. and European clinical infections and
meat products, FQr Salmonella are more frequently isolated out-
side the United States and Europe (30, 59–62). Culture and isola-
tion of NALr Salmonella effectively monitor emerging FQr Salmo-
nella since NALr Salmonella commonly has a single point
mutation in gyrA, while FQr Salmonella has additional point mu-
tations in gyrA (63–65). Reduced susceptibility to fluoroquinolo-
nes is frequently observed with NALr Salmonella, and NALr Sal-
monella infections have been reported in the United States (63,
65–67). However, NALr Salmonella was detected in only one sam-
ple in the present study, but the NALr Salmonella isolate from this
sample was also CIP resistant.
In the United States, 3GCr E. coli has been isolated from ani-
mal, food, and human sources (30). Commensal 3GCr E. coli in
cattle feedlots represents a subpopulation of the generic E. coli
hide and fecal populations (36, 68–70). Resistance to third-gener-
ation cephalosporins in both E. coli and Salmonella is commonly
conferred by a cephamycinase encoded by a blaCMY gene harbored
on a conjugative plasmid (15, 30, 71–73). The nucleotide se-
quences of blaCMY bearing conjugative plasmids harbored by E.
coli and Salmonella are conserved (72, 73). Thus, E. coli in animals,
foods, and humans is theorized to be a reservoir of 3GCr capable of
transfer to pathogens, including Salmonella (15, 74–82). Salmo-
nella andE. coli resistance to third-generation cephalosporins may
be conferred by a CTX-M type beta-lactamase, as well, encoded by
blaCTX-M. Salmonella with blaCTX-M is rarely isolated in the United
States, but increasing reports of blaCTX-M 3GC
r E. coli isolated
from food animal feces have raised fears that blaCTX-M 3GC
r Sal-
monella may emerge in the United States (45, 71, 83, 84). In the
present study, the blaCTX-M gene was detected from 36.7% of 3GC
r
E. coli isolates tested but from none of the 3GCr Salmonella isolates
tested. Conversely, the blaCMY gene was detected in 63.3% of 3GC
r
E. coli isolates and all 3GCr Salmonella isolates. We conclude that
in the examined environments blaCTX-M E. coli was not a reservoir
of blaCTX-M for Salmonella.
Sulfamethoxazole and trimethoprim inhibit synthesis of tetra-
hydrofolate at two different steps. Accordingly, human clinical
COTr E. coli isolates typically harbor at least one sul gene encoding
a dihydropteroate synthase insensitive to sulfonamide and at least
TABLE 7 E. coli and Salmonella isolate susceptibilities to 15 antimicrobial agents
Organisma
No. of
isolates
% of isolates resistant tob:
AUG AMP AZI FOX TIO AXO CHL CIP GEN KAN NAL STR FIS TET COT
3GCr E. coli 150 64.7 100.0 20.0 64.0 100.0 100.0 69.3 10.7 6.7 4.0 12.7 65.3 68.7 97.3 5.3
COTr E. coli 160 4.4 60.0 2.5 4.4 4.4 4.4 43.8 4.4 3.1 33.8 7.5 72.5 100.0 91.3 100.0
Generic Salmonella 110 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 20.9 0.0
3GCr Salmonella 37 100.0 100.0 0.0 97.3 100.0 100.0 29.7 0.0 0.0 0.0 0.0 29.7 97.3 97.3 0.0
NALr Salmonella 1 0.0 100.0 0.0 0.0 0.0 0.0 0.0 100.0 100.0 0.0 100.0 0.0 0.0 100.0 0.0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; NALr, nalidixic acid resistant.
b AMC, amoxicillin-clavulanic acid; AMP, ampicillin; AZI, azithromycin; FOX, cefoxitin; TIO, ceftiofur; AXO, ceftriaxone; CHL, chloramphenicol; CIP, ciprofloxacin; GEN,
gentamicin; KAN, kanamycin; NAL, nalidixic acid; STR, streptomycin; FIS, sulfisoxazole; TET, tetracycline; COT, trimethoprim-sulfamethoxazole.
TABLE 8 Detection of ExPEC virulence-associated markers in E. coli isolatesa
Organism No. of isolates % ExPEC
% of isolates with indicated marker
afa/dra iutA kpsMT II papA papC sfa/foc
Generic E. coli 232 0.0 0.0 1.7 0.9 9.5 1.3 0.0
3GCr E. coli 150 0.0 0.0 0.7 0.0 0.0 0.0 0.0
COTr E. coli 160 1.3 0.0 50.6 0.6 0.0 1.3 0.0
a 3GCr, third-generation cephalosporin resistant; COTr, trimethoprim-sulfamethoxazole resistant; ExPEC, extraintestinal pathogenic E. coli.
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one dfrA gene encoding a dihydrofolate reductase insensitive to
trimethoprim (46, 85–88). At least one sul gene was detected in
99.4% of the 150 COTr E. coli isolates examined here. Prevalences
of sul1, sul2, and sul3were 70.6, 39.4, and 22.5%, respectively. This
pattern of sul gene frequencies contrasted with the pattern ob-
served in most studies of human COTr E. coli isolates: sul2 sul1
 sul3 (86, 87, 89, 90). However, the pattern sul1 sul2 sul3 has
been observed in at least one study of human COTr E. coli isolates
(88). At least one of four common dfrA genes (dfrA1, dfrA5, dfrA7/
dfrA17, and dfrA12) was detected in 91.3% of the COTr E. coli
isolated in the present study. The predominate gene was dfrA5,
detected from 51.3% of isolates, which contrasted with the pre-
dominance of dfrA1 and dfrA17 in human COTr E. coli isolates
(46).
E. coli causes 75 to 95% of human UTIs in the United States
(22). ExPEC differ from both commensal E. coli and Shiga-toxi-
genic E. coli in their phylogeny and virulence factors (32, 91–93).
In the present study, 0.0, 0.0, and 1.3% of generic E. coli, 3GCr E.
coli, and COTr E. coli isolates were ExPEC, respectively (Table 8).
Similarly Xia et al. (21) determined that 3.4% of 293 E. coli isolates
from retail ground beef were ExPEC. In addition, we found that
ExPEC were not present on any pre-evisceration carcass, final car-
cass, or strip loin. A literature review by Nordstrom et al. (18) put
forth the opinion that meat products (including ground beef)
were a source of ExPEC that cause human UTIs. Our findings
suggest that beef cattle and beef products are not significant
sources of ExPEC causing human UTIs. However, stronger con-
clusions will require a broader data set than that examined here.
In summary, we clearly demonstrated that AMR subpopula-
tions of E. coli and Salmonella exist on the hides and in the feces of
beef cattle both at feedlots and during processing. Moreover, we
demonstrated that COTr E. coli and 3GCr E. coli concentrations on
hides may change between feedlot and processing, a finding con-
sistent with the “lairage contamination” model for E. coli
O157:H7 and Salmonella. Enumeration of COTr E. coli and 3GCr
E. coli subpopulations on hides during processing determined that
these concentrations were correlated to carcass contamination,
analogous to the results of E. coli O157:H7 and Salmonella studies
examining hide-to-carcass contamination. The present study thus
demonstrated that currently used processing interventions are ef-
fective for AMR bacteria since 3GCr E. coli and COTr E. coli were
present on 100% of hides when processing began (Table 4) but the
prevalences of 3GCr E. coli and COTr E. coli on final carcasses were
each 0.5% (Table 6).
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Figure	  S1.	  Flow	  diagram	  of	  hide	  and	  pre-­‐evisceration	  carcass	  sample	  processing.	  BPW,	  buffered	  peptone	  water.	  TSB-­‐PO,	  phosphate	  buffered	  tryptic	  soy	  broth.	  CEC,	  CHROMagar	  E.	  coli	  plate.	  CEC+CTX,	  CEC	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  CEC+COT,	  CEC	  supplemented	  with	  4	  mg	  liter-­‐1	  of	  trimethoprim	  and	  76	  mg	  liter-­‐1	  sulfamethoxazole	  plate.	  XLDtnc,	  xylose-­‐lysine-­‐desoxycholate	  agar	  (XLD)	  supplemented	  with	  4.6	  mg	  liter-­‐1	  tergitol,	  15	  mg	  liter-­‐1	  novobiocin,	  and	  5	  mg	  liter-­‐1	  cefesulodin	  plate.	  XLD+CTX,	  XLD	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  XLD+NAL,	  XLD	  supplemented	  with	  32	  mg	  liter-­‐1	  nalidixic	  acid	  plate.	  MAC,	  MacConkey	  broth.	  MAC+CTX,	  MAC	  supplemented	  with	  2.4	  mg	  liter-­‐1	  cefotaxime.	  MAC+COT,	  MAC	  supplemented	  with	  4.8	  mg	  liter-­‐1	  trimethoprim	  and	  91.2	  mg	  liter-­‐1	  sulfamethoxazole.	  RVS,	  Rappaport-­‐Vassiliadis	  soy	  peptone	  broth.	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Figure	  S2.	  Flow	  diagram	  of	  final	  carcass	  sample	  processing.	  BPW,	  buffered	  peptone	  water.	  TSB-­‐PO,	  phosphate	  buffered	  tryptic	  soy	  broth.	  CEC,	  CHROMagar	  E.	  coli	  plate.	  CEC+CTX,	  CEC	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  CEC+COT,	  CEC	  supplemented	  with	  4	  mg	  liter-­‐1	  of	  trimethoprim	  and	  76	  mg	  liter-­‐1	  sulfamethoxazole	  plate.	  XLDtnc,	  xylose-­‐lysine-­‐desoxycholate	  agar	  (XLD)	  supplemented	  with	  4.6	  mg	  liter-­‐1	  tergitol,	  15	  mg	  liter-­‐1	  novobiocin,	  and	  5	  mg	  liter-­‐1	  cefesulodin	  plate.	  XLD+CTX,	  XLD	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  XLD+NAL,	  XLD	  supplemented	  with	  32	  mg	  liter-­‐1	  nalidixic	  acid	  plate.	  MAC,	  MacConkey	  broth.	  MAC+CTX,	  MAC	  supplemented	  with	  2.4	  mg	  liter-­‐1	  cefotaxime.	  MAC+COT,	  MAC	  supplemented	  with	  4.8	  mg	  liter-­‐1	  trimethoprim	  and	  91.2	  mg	  liter-­‐1	  sulfamethoxazole.	  RVS,	  Rappaport-­‐Vassiliadis	  soy	  peptone	  broth.	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Figure	  S3.	  Flow	  diagram	  of	  fecal	  swab	  sample	  processing.	  TSB-­‐PO,	  phosphate	  buffered	  tryptic	  soy	  broth.	  CEC,	  CHROMagar	  E.	  coli	  plate.	  CEC+CTX,	  CEC	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  CEC+COT,	  CEC	  supplemented	  with	  4	  mg	  liter-­‐1	  of	  trimethoprim	  and	  76	  mg	  liter-­‐1	  sulfamethoxazole	  plate.	  XLDtnc,	  xylose-­‐lysine-­‐desoxycholate	  agar	  (XLD)	  supplemented	  with	  4.6	  mg	  liter-­‐1	  tergitol,	  15	  mg	  liter-­‐1	  novobiocin,	  and	  5	  mg	  liter-­‐1	  cefesulodin	  plate.	  XLD+CTX,	  XLD	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  XLD+NAL,	  XLD	  supplemented	  with	  32	  mg	  liter-­‐1	  nalidixic	  acid	  plate.	  MAC,	  MacConkey	  broth.	  MAC+CTX,	  MAC	  supplemented	  with	  2.4	  mg	  liter-­‐1	  cefotaxime.	  MAC+COT,	  MAC	  supplemented	  with	  4.8	  mg	  liter-­‐1	  trimethoprim	  and	  91.2	  mg	  liter-­‐1	  sulfamethoxazole.	  RVS,	  Rappaport-­‐Vassiliadis	  soy	  peptone	  broth.	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Figure	  S4.	  Flow	  diagram	  of	  strip	  loin	  sample	  processing.	  TSB-­‐PO,	  phosphate	  buffered	  tryptic	  soy	  broth.	  CEC,	  CHROMagar	  E.	  coli	  plate.	  CEC+CTX,	  CEC	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  CEC+COT,	  CEC	  supplemented	  with	  4	  mg	  liter-­‐1	  of	  trimethoprim	  and	  76	  mg	  liter-­‐1	  sulfamethoxazole	  plate.	  XLDtnc,	  xylose-­‐lysine-­‐desoxycholate	  agar	  (XLD)	  supplemented	  with	  4.6	  mg	  liter-­‐1	  tergitol,	  15	  mg	  liter-­‐1	  novobiocin,	  and	  5	  mg	  liter-­‐1	  cefesulodin	  plate.	  XLD+CTX,	  XLD	  supplemented	  with	  2	  mg	  liter-­‐1	  cefotaxime	  plate.	  XLD+NAL,	  XLD	  supplemented	  with	  32	  mg	  liter-­‐1	  nalidixic	  acid	  plate.	  MAC,	  MacConkey	  broth.	  MAC+CTX,	  MAC	  supplemented	  with	  2.4	  mg	  liter-­‐1	  cefotaxime.	  MAC+COT,	  MAC	  supplemented	  with	  4.8	  mg	  liter-­‐1	  trimethoprim	  and	  91.2	  mg	  liter-­‐1	  sulfamethoxazole.	  RVS,	  Rappaport-­‐Vassiliadis	  soy	  peptone	  broth.	  	  
